Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Revista Argentina De Microbiologia|December 3, 2014
Rich bacterial assemblages from Maritime Antarctica (Potter Cove, South Shetlands) reveal several kinds of endemic and undescribed phylotypesIgnacio A Landone Vescovo, Marcelo D Golemba, Federico A Di Lello, et al.
Journal of Clinical Microbiology|August 22, 2014
Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatmentJavier R Guelfo, Juan Macias, Karin Neukam, et al.
Vaccine|February 17, 2020
Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccinationFederico A Di Lello, Jorgelina Blejer, Adriana Alter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 2, 2025
Hepatitis A and hepatitis E virus seroprevalence in Paraguay: first survey among blood donorsDiego M Flichman, Nelson Marquez, Victor A Sánchez, et al.
Scientific Reports|April 27, 2026
Nationwide seroprevalence study of hepatitis B and hepatitis C viruses among blood donors in ParaguayFederico A Di Lello, Nelson Marquez, Nathalia P Navarro, et al.
Antiviral Research|July 4, 2012
HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infectionKarin Neukam, Silvia García-Rey, Celia Cifuentes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 20, 2022
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysisMatías J Pereson, Lucas Amaya, Karin Neukam, et al.
Plos One|December 24, 2010
Genetic history of hepatitis C virus in Venezuela: high diversity and long time of evolution of HCV genotype 2Maria Z Sulbarán, Federico A Di Lello, Yoneira Sulbarán, et al.
AIDS (London, England)|March 3, 2012
LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patientsAntonio Rivero-Juarez, Angela Camacho, Antonio Caruz, et al.
Pageof 4